未登录
分享
收藏Multicenter phase I dose escalation and expansion study of pyrotinib in combination with camrelizumab and chemotherapy as first-line treatment for HER2-positive advanced gastric and gastroesophageal junction adenocarcinoma吡托替尼联合卡姆瑞珠单抗和化疗作为一线治疗HER2-positive晚期胃和胃食管交界处腺癌的多中心I期剂量递增和扩展研究
Li, Sheng; Bao, Jun; Li, Xiaoyou; Yang, Quanliang; Xu, Junying; Chen, Surong; Feng, Ge; Gao, Chao; Feng, Lin; Lu, Bin; Miao, Min; Ni, Xinchu; Wang, Guofang; Yang, Lei; Zhu, Liangjun
分享
收藏
分享
收藏